Entrepreneur Michael Arnolt teamed with an inventor more than 20 years ago to launch an enterprise that has sold thousands of steel therapy instruments and trained thousands of clinicians.
At issue in the five-year legal dispute was whether Dr. Rick Sasso was properly compensated for various inventions, and whether Minnesota-based Medtronic paid him sufficient royalties as spelled out in their agreements.
The decades-old system has long been criticized by experts for failing to catch problems with risky implants and medical instruments.
The company, which employs more than 3,000 on the northeast side, has been struggling on the diabetes side of its business. To bounce back, it is investing heavily in diagnostics, and is working to commercialize several products it hopes will be game-changers.
An Indianapolis-based company that makes handheld medical testing devices plans to move its 150 employees to a new headquarters in Boone County, where it will hire an additional 50 to 70 workers.
Greenlight Guru grew from 19 to 31 employees in the last year and expects to add nine more during the first quarter of this year.
The medical-device industry will see a resumption of the 2.3 percent federal excise tax beginning this month, following a two-year moratorium that expired Dec. 31.
Innovative Health Solutions Inc. recently received FDA approval for a device that treats opioid withdrawal symptoms.
Nearly 3,000 people have sued the Bloomington-based device maker, claiming the filters malfunctioned, sometimes piercing organs.
The Carmel-based company makes a device that uses sound waves to help position and monitor breathing tubes for newborns in hospitals.
The state is asking vendors to submit bid packages by June 12 for a drug whose price has spiked in recent years.
Indianapolis-based software company Greenlight.guru has moved operations from one downtown facility to another to accommodate expansion.
For years, medical-device makers in Indiana and around the nation have insisted that the 2.3 percent tax on sales to help fund the Affordable Care Act has hurt business and slowed innovation.
Currently, only about 2-4 percent of U.S. brain surgeries for tumors, strokes and other abnormalities are done with NICO’s low-invasive approach.
Mylan will start selling a cheaper version of the emergency allergy treatment after absorbing waves of criticism over a growing list price that made it unaffordable for many patients.
Indianapolis-based Simon Property Group Inc. and Warsaw’s Zimmer Biomet Holdings vaulted back among the top 500 this year, while local oil refiner Calumet Specialty Products Partners plummeted.
It’s the largest recall in recent years for Cook, which previously had issued four recalls covering more than 400,000 catheters and pressuring monitoring sets in the past two years.
PTS Diagnostics, with about 150 employees in Indianapolis, said Monday it has entered a definitive agreement to be acquired by China-based Sinocare Inc.